{"id":"https://openalex.org/W2083499348","doi":"https://doi.org/10.1097/00004850-200501000-00002","title":"Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients","display_name":"Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients","alternate_titles":[],"publication_year":2004,"publication_date":"2004-12-15","ids":{"openalex":"https://openalex.org/W2083499348","doi":"https://doi.org/10.1097/00004850-200501000-00002","mag":"2083499348","pmid":"https://pubmed.ncbi.nlm.nih.gov/15602109"},"language":"en","primary_location":{"id":"doi:10.1097/00004850-200501000-00002","doi":"https://doi.org/10.1097/00004850-200501000-00002","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-200501000-00002","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2083499348"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019050839","display_name":"John J. Worthington","orcid":"https://orcid.org/0000-0002-1429-5669","observed_orcids":["https://orcid.org/0000-0002-1429-5669"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John J. Worthington","raw_affiliation_strings":["Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043205589","display_name":"Gustavo Kinrys","orcid":"https://orcid.org/0000-0002-5845-8327","observed_orcids":["https://orcid.org/0000-0002-5845-8327"]},"institutions":[{"id":"https://openalex.org/I124574311","display_name":"Cambridge Health Alliance","ror":"https://ror.org/059c3mv67","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I124574311"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Gustavo Kinrys","raw_affiliation_strings":["Anxiety","Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA","and requests for reprints to Gustavo Kinrys, Cambridge Health Alliance, Harvard Medical School, Department of Psychiatry, 1493 Cambridge Street, Cambridge, MA 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anxiety","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"and requests for reprints to Gustavo Kinrys, Cambridge Health Alliance, Harvard Medical School, Department of Psychiatry, 1493 Cambridge Street, Cambridge, MA 02139, USA","institution_ids":["https://openalex.org/I124574311","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052081323","display_name":"Lisa E. Wygant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lisa E. Wygant","raw_affiliation_strings":["Anxiety","Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anxiety","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065758533","display_name":"Mark H. Pollack","orcid":"https://orcid.org/0000-0001-7240-2162","observed_orcids":["https://orcid.org/0000-0001-7240-2162"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark H. Pollack","raw_affiliation_strings":["Center for","Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5043205589"],"corresponding_institution_ids":["https://openalex.org/I124574311","https://openalex.org/I136199984"],"apc_list":null,"apc_paid":null,"fwci":5.4612,"has_fulltext":false,"cited_by_count":128,"citation_normalized_percentile":{"value":0.96137764,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"20","issue":"1","first_page":"9","last_page":"11"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":1.0},{"id":"https://openalex.org/keywords/augmentation-therapy","display_name":"augmentation therapy","score":0.593999981880188},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.984000027179718},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.9879999756813049},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.9909999966621399},{"id":"https://openalex.org/keywords/panic-disorder","display_name":"panic disorder","score":0.8379999995231628},{"id":"https://openalex.org/keywords/generalized-anxiety-disorder","display_name":"generalized anxiety disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/social-anxiety","display_name":"social anxiety","score":0.8240000009536743},{"id":"https://openalex.org/keywords/posttraumatic-stress-disorder","display_name":"post-traumatic stress disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9629999995231628}],"concepts":[{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.9637120962142944},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.7316156625747681},{"id":"https://openalex.org/C2777529043","wikidata":"https://www.wikidata.org/wiki/Q741713","display_name":"Panic disorder","level":3,"score":0.6507315039634705},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.584144651889801},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5690633058547974},{"id":"https://openalex.org/C2777545354","wikidata":"https://www.wikidata.org/wiki/Q3557657","display_name":"Social anxiety","level":3,"score":0.48173239827156067},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.48101338744163513},{"id":"https://openalex.org/C2779911313","wikidata":"https://www.wikidata.org/wiki/Q845224","display_name":"Generalized anxiety disorder","level":3,"score":0.4661577641963959},{"id":"https://openalex.org/C2776317618","wikidata":"https://www.wikidata.org/wiki/Q544006","display_name":"Anxiety disorder","level":3,"score":0.4607902467250824},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.426858127117157},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33215194940567017},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3314347267150879},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.2743426561355591},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068180","descriptor_name":"Aripiprazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004850-200501000-00002","doi":"https://doi.org/10.1097/00004850-200501000-00002","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-200501000-00002","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:15602109","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15602109","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W59589068","https://openalex.org/W1966424565","https://openalex.org/W2005066505","https://openalex.org/W2020597987","https://openalex.org/W2029066588","https://openalex.org/W2054952272","https://openalex.org/W2070895158","https://openalex.org/W2092430566","https://openalex.org/W2114693958","https://openalex.org/W2159061031","https://openalex.org/W2296976918","https://openalex.org/W2503799583","https://openalex.org/W3191110341"],"related_works":["https://openalex.org/W2156239318","https://openalex.org/W2064002445","https://openalex.org/W38443713","https://openalex.org/W2094133687","https://openalex.org/W2095109387","https://openalex.org/W2371510970","https://openalex.org/W2313491356","https://openalex.org/W2889121537","https://openalex.org/W1992490627","https://openalex.org/W2046695234"],"abstract_inverted_index":{"More":[0],"than":[1],"half":[2],"of":[3,13,68,89,105,110,122,131,150],"anxiety":[4,26,46,52,55,126,174],"and":[5,25,31,45,56,74,125,154,173],"depression":[6,24,44,124],"patients":[7,28,42,135,169],"treated":[8],"with":[9,34,43,78,148,170],"an":[10,62,137,166],"adequate":[11],"course":[12],"antidepressants":[14],"fail":[15],"to":[16,30,65,146,192],"fully":[17],"improve.":[18],"We":[19,39],"retrospectively":[20],"examined":[21],"whether":[22],"treatment-resistant":[23],"disorder":[27],"responded":[29],"tolerated":[32],"augmentation":[33,77,147,167],"the":[35,85,93,96,129],"atypical":[36],"antipsychotic,":[37],"aripiprazole.":[38,79],"report":[40],"on":[41],"disorders,":[47],"including":[48],"panic":[49],"disorder,":[50,53,59],"generalized":[51],"social":[54],"post-traumatic":[57],"stress":[58],"who":[60,75],"had":[61],"incomplete":[63],"response":[64,145],"a":[66,183],"variety":[67],"selective":[69],"serotonin":[70],"reuptake":[71],"inhibitors":[72],"(SSRIs)":[73],"received":[76,107],"The":[80,157],"primary":[81],"outcome":[82],"measure":[83],"was":[84,99],"Clinical":[86],"Global":[87],"Impression":[88],"Improvement":[90],"(CGI-I).":[91],"In":[92],"intent-to-treat":[94],"analysis,":[95],"mean+/-SD":[97],"CGI-S":[98],"3.8+/-1.3":[100],"at":[101,128],"endpoint.":[102],"Fifty-nine":[103],"percent":[104],"subjects":[106],"CGI-I":[108],"ratings":[109],"1":[111],"or":[112,116],"2,":[113],"'much":[114],"improved'":[115],"'very":[117],"much":[118],"improved,'":[119],"in":[120],"terms":[121],"their":[123],"symptoms":[127],"end":[130],"12":[132],"weeks.":[133],"Several":[134],"showed":[136],"early":[138],"(weeks":[139],"1-5),":[140],"as":[141,143,165],"well":[142],"sustained,":[144],"doses":[149],"aripiprazole":[151,161],"between":[152],"15":[153],"30":[155],"mg/day.":[156],"results":[158],"suggest":[159],"that":[160],"may":[162],"be":[163],"effective":[164],"for":[168],"persistent":[171],"depressive":[172],"disorders":[175],"despite":[176],"initial":[177],"SSRI":[178],"treatment.":[179],"Because":[180],"this":[181],"is":[182],"retrospective":[184],"case":[185],"review,":[186],"further":[187],"prospective":[188],"studies":[189],"are":[190],"required":[191],"confirm":[193],"these":[194],"findings.":[195]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2083499348","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
